ISRG

Intuitive Surgical, Inc.
Medical Devices

Cash & Equivalents

$3.37B
As of 2025-12-31
Current Price: $450.62 (as of 2026-04-12)

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $3.37B
Total Obligations: -$2.18B
$1.19B
Per share: $3.35
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $3.37B
AR: $1.53B
Total Obligations: -$2.18B
$2.72B
Per share: $7.65
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $3.37B
AR: $1.53B
Inventory: $1.84B
Total Obligations: -$2.18B
$4.56B
Per share: $12.84
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$1.19B$3.35
Liquid Liquidation Value$2.72B$7.65
Operating Liquidation Value$4.56B$12.84

Key Components (as of 2025-12-31)

Cash & Equivalents$3.37B
Accounts Receivable$1.53B
Inventory$1.84B
Current Liabilities$2.01B
Long-term DebtN/A
Op. Lease Liability$170.90M
Finance LeaseN/A
Shares Outstanding355.1M

Explore all 288 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31 $3.37B $1.53B $1.84B $255.10M $2.01B N/A $170.90M N/A
2025-09-30 $2.81B $1.26B $1.78B $291.20M $1.80B N/A N/A N/A
2025-06-30 $3.40B $1.27B $1.67B $266.80M $1.69B N/A N/A N/A
2025-03-31 $2.57B $1.22B $1.55B $276.20M $1.54B N/A N/A N/A
2024-12-31 $2.03B $1.23B $1.49B $193.40M $1.75B N/A $146.00M N/A
2024-09-30 $2.41B $1.15B $1.48B $218.70M $1.68B N/A N/A N/A
2024-06-30 $3.04B $1.11B $1.38B $194.40M $1.49B N/A N/A N/A
2024-03-31 $2.84B $1.13B $1.30B $194.40M $1.38B N/A N/A N/A

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-03 View
2025-09-30 10-Q 2025-10-22 View
2025-06-30 10-Q 2025-07-23 View
2025-03-31 10-Q 2025-04-23 View
2024-12-31 10-K 2025-01-31 View
2024-09-30 10-Q 2024-10-18 View
2024-06-30 10-Q 2024-07-19 View
2024-03-31 10-Q 2024-04-19 View